Cargando…

Response to exercise in patients with pulmonary arterial hypertension treated with combination therapy

Pulmonary arterial hypertension (PAH)-specific combination therapy improves pulmonary haemodynamics at rest in patients with PAH; nevertheless, exertional dyspnoea remains. We investigated pulmonary haemodynamic response to exercise, and the relationship to ventilatory efficiency and hypoxaemia in p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nishizaki, Mari, Ogawa, Aiko, Matsubara, Hiromi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836646/ https://www.ncbi.nlm.nih.gov/pubmed/33532477 http://dx.doi.org/10.1183/23120541.00725-2020

Ejemplares similares

High Right Ventricular Afterload during Exercise in Patients with Pulmonary Arterial Hypertension
por: Nishizaki, Mari, et al.
Publicado: (2021)

Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension concomitant with Klippel–Trenaunay–Weber syndrome
por: Suetomi, Takeshi, et al.
Publicado: (2022)

Change in R wave in lead V1 predicts survival of patients with pulmonary arterial hypertension
por: Sato, Shinji, et al.
Publicado: (2018)

Balloon Pulmonary Angioplasty: A Treatment Option for Inoperable Patients with Chronic Thromboembolic Pulmonary Hypertension
por: Ogawa, Aiko, et al.
Publicado: (2015)

Treatment of Vascular Injury During Balloon Pulmonary Angioplasty in Patients With Chronic Thromboembolic Pulmonary Hypertension
por: Ejiri, Kentaro, et al.
Publicado: (2022)

Epoprostenol sodium for treatment of pulmonary arterial hypertension
por: Saito, Yukihiro, et al.
Publicado: (2015)

Investigation of safety and efficacy of the new more thermostable formulation of Flolan (epoprostenol) in Japanese patients with pulmonary arterial hypertension (PAH)—An open-label, single-arm study
por: Mihara, Kazuko, et al.
Publicado: (2018)

3D in vitro Model of Vascular Medial Thickening in Pulmonary Arterial Hypertension
por: Morii, Chiharu, et al.
Publicado: (2020)

Antiproliferative effect of selexipag active metabolite MRE‐269 on pulmonary arterial smooth muscle cells from patients with chronic thromboembolic pulmonary hypertension
por: Kuramoto, Kazuya, et al.
Publicado: (2023)

Thrombin‐mediated activation of Akt signaling contributes to pulmonary vascular remodeling in pulmonary hypertension
por: Ogawa, Aiko, et al.
Publicado: (2013)

Improvements in French risk stratification score were correlated with reductions in mean pulmonary artery pressure in pulmonary arterial hypertension: a subanalysis of the Japan Pulmonary Hypertension Registry (JAPHR)
por: Tamura, Yuichi, et al.
Publicado: (2021)

A burden of rare variants in BMPR2 and KCNK3 contributes to a risk of familial pulmonary arterial hypertension
por: Higasa, Koichiro, et al.
Publicado: (2017)

Triple oral combination therapy with macitentan, riociguat, and selexipag for pulmonary arterial hypertension
por: Momoi, Mizuki, et al.
Publicado: (2021)

Dasatinib-Induced Pulmonary Arterial Hypertension Treated with Upfront Combination Therapy
por: Nishimori, Makoto, et al.
Publicado: (2018)

Safety and Efficacy of Ambrisentan–Phosphodiesterase Type 5 (PDE5) Inhibitor Combination Therapy for Japanese Pulmonary Arterial Hypertension Patients in Real-World Clinical Practice
por: Kataoka, Masaharu, et al.
Publicado: (2019)

Importance of differential diagnosis of pulmonary hypertension
por: Ogawa, Aiko
Publicado: (2013)

Pulmonary Arterial Hypertension Specific Therapy in Patients with Combined Post- and Precapillary Pulmonary Hypertension
por: Alfraidi, Hassan, et al.
Publicado: (2018)

Pulmonary Arterial Hypertension: Combination Therapy in Practice
por: Burks, Marsha, et al.
Publicado: (2018)

Goal-Oriented Sequential Combination Therapy Evaluated Using Cardiopulmonary Exercise Parameters for the Treatment of Newly Diagnosed Pulmonary Arterial Hypertension　― Goal-Oriented Therapy Evaluated by Cardiopulmonary Exercise Testing for Pulmonary Arterial Hypertension (GOOD EYE) ―
por: Hirashiki, Akihiro, et al.
Publicado: (2019)

Combination of rescue balloon pulmonary angioplasty and riociguat therapy for chronic thromboembolic pulmonary hypertension with nonsustained polymorphic ventricular tachycardia: A case report
por: Fukuda, Yoshitake, et al.
Publicado: (2023)

Exercise Capacity and Ventilatory Efficiency in Patients With Pulmonary Arterial Hypertension
por: Tobita, Kazuki, et al.
Publicado: (2023)

Apoptosis-based therapy to treat pulmonary arterial hypertension
por: Suzuki, Yuichiro J., et al.
Publicado: (2016)

Relevance of comorbidities on initial combination therapy in pulmonary arterial hypertension
por: Badagliacca, Roberto, et al.
Publicado: (2022)

Exercise Intolerance in Pulmonary Arterial Hypertension
por: Fowler, Robin M., et al.
Publicado: (2012)

Medium-term health-related quality of life in patients with pulmonary arterial hypertension treated with goal-oriented sequential combination therapy based on exercise capacity
por: Hirashiki, Akihiro, et al.
Publicado: (2019)

Combination targeted pulmonary hypertension therapy in the resolution of Dasatinib-associated pulmonary arterial hypertension
por: Jose, Arun, et al.
Publicado: (2017)

The evolving landscape of combination therapy for pulmonary arterial hypertension
por: Griffin, Matthew, et al.
Publicado: (2016)

The role of combination therapy in managing pulmonary arterial hypertension
por: Ghofrani, Hossein-Ardeschir, et al.
Publicado: (2014)

Dynamic right ventricular–pulmonary arterial uncoupling during maximum incremental exercise in exercise pulmonary hypertension and pulmonary arterial hypertension
por: Singh, Inderjit, et al.
Publicado: (2019)

MRI assessment of aortic flow in patients with pulmonary arterial hypertension in response to exercise
por: Macdonald, Jacob A., et al.
Publicado: (2018)

Exercise feature and predictor of prognosis in patients with pulmonary artery stenosis‐associated pulmonary hypertension
por: Li, Xin, et al.
Publicado: (2022)

Cost‐Effectiveness of Combination Therapy for Patients With Systemic Sclerosis–Related Pulmonary Arterial Hypertension
por: Tran‐Duy, An, et al.
Publicado: (2021)

Chronic Thromboembolic Pulmonary Hypertension: Endovascular Treatment
por: Ahn, Chul-Min, et al.
Publicado: (2019)

Pulmonary arterial wedge pressure increase during exercise in patients diagnosed with pulmonary arterial or chronic thromboembolic pulmonary hypertension
por: Müller, Julian, et al.
Publicado: (2023)

Nanoparticle-Mediated Drug Delivery System for Pulmonary Arterial Hypertension
por: Nakamura, Kazufumi, et al.
Publicado: (2017)

Initial combination therapy of macitentan and tadalafil in pulmonary arterial hypertension
por: Sitbon, Olivier, et al.
Publicado: (2020)

Pulmonary rehabilitation and exercise in pulmonary arterial hypertension: An underutilized intervention
por: Sahni, Sonu, et al.
Publicado: (2015)

Exercise-Induced Changes in Pulmonary Artery Stiffness in Pulmonary Hypertension
por: Forouzan, Omid, et al.
Publicado: (2019)

Efficacy, safety, and pharmacokinetics of inhaled treprostinil in Japanese patients with pulmonary arterial hypertension
por: Kuwana, Masataka, et al.
Publicado: (2023)

The Characteristics of Treated Pulmonary Arterial Hypertension Patients in Ontario
por: Vaid, Haris M., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_915r8t69i860qftn7fkom1lkcm